医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mannatech’s Global Scientific Advisory Board Supports Company’s Commitment to Innovation and Science

2017年05月10日 AM12:24
このエントリーをはてなブックマークに追加


 

GUANGZHOU, China

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, has assembled a group of top-tier, independent scientists to lead its Global Scientific Advisory Board that will support the company’s continued commitment to providing groundbreaking, science-backed nutritional supplements to its worldwide customer base.

Mannatech provides top-quality nutritional supplements for families in China through its website www.MeiTaiChina.com. Mannatech’s products include the innovative fat-loss system, TruHealth™ and its family of unmatched Ambrotose® nutritional products.

“The members of Mannatech’s Global Scientific Advisory Board are committed to science and the truth that their research and findings bring,” said Mannatech’s CEO and President, Alfredo “Al” Bala. “Mannatech has built its worldwide business on science-backed product technology, and this group will help us continue that tradition and take us into new, transformational areas of health and wellness, while ensuring we stay on the path of scientific proof and validation.”

This Global Scientific Advisory Board is part of CEO and President Al Bala’s vision for ensuring that Mannatech delivers innovative nutritional technology and products that are supported by clinical trials and scientific validation. The board safeguards that Mannatech products are what they say they are and can provide real results by improving the overall wellness of customers.

Mannatech’s Global Scientific Advisory Board is specifically charged to review each new and existing product to ensure ingredients and formulations are kept to a high standard and are in-line with the latest research. The board will also be called upon to make suggestions for new products. Additionally, board members will provide education and training to Associates and customers on health and wellness topics.

The Mannatech Global Scientific Advisory Board consists of third-party, independent scientists from around the world. The board members include:

  • Azita Alavi, BSc(Hons), M.Phil, Ph.D.
  • Richard J. Bloomer, Ph.D.
  • Stephen Boyd, MD, Ph.D. (Vice Chairman)
  • Woo-Sik Jeong, Ph.D.
  • Jun Liao, Ph.D
  • Charl Marai, DEmed
  • Francesco Marotta, MD, Ph.D.
  • Erika Nelson, Ph.D.
  • Steve Nugent, PsyD, PDD, MA, CNC (Chairman)
  • Rolando Maddela, MD, MPH, CCRP (Executive Secretary)
  • Chandan Prasad, BSc(Hons), MS, Ph.D.
  • Emma Roca, MS
  • William Sanchez, MD

Mannatech’s Senior Global Wellness Director, Dr. Steve Nugent, will serve as Chairman of the Global Scientific Advisory Board and Dr. Rolando Maddela, Mannatech’s Director of Clinical Research and Scientific Affairs will serve as the Executive Secretary. Mr. Tait Switzer, Vice President of Research and Development will also support the scientific advisory board members.

“Innovative technology supported by a sound scientific foundation is at the heart of Mannatech’s products and ultimately, its success,” said Dr. Nugent. “Mannatech’s Global Scientific Advisory Board will ensure that we remain on the cutting edge of nutritional technology. This is an amazing group of minds that are focused on making the world a better place. By working together, we can find more ways to improve the health and wellness of as many people as possible. These individuals will retain their independence, but their position on the advisory board will give them a unique vantage point to the health and wellness community around the globe, as well as an opportunity to share their point of view with an audience that is in need of their service.”

Mannatech’s commitment to science includes clinical studies on its product technology and a global patent program. Since its founding, Mannatech has invested more than $50 million in research and development that includes a clinical testing program for a number of its products that helps supports core product claims and ensures that the company delivers what is promised Mannatech’s core technology has been included in 17 human clinical trials that have been published, 12 of which were double-blind, placebo-controlled studies — the gold standard for product validation.

Mannatech’s Global Science Advisory Board began its work in 2016 and meets to provide input to Mannatech on a regular basis.

For more information about Mannatech and its products, please visit www.MeiTaiChina.com. †^

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience that makes a difference in the lives of people across the world. Through its innovative Glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in 26 markets, Mannatech is committed to transforming lives. For more information, visit www.MeiTaiChina.com.

Read more about Mannatech’s forward-looking statements.

†Customers who invite other customers to the Mannatech China cross-border e-commerce site gain rewards for future product purchases or cash redemption. The e-commerce business model is not multi-level marketing or direct selling.

^Mannatech’s cross-border e-commerce model in China is a different opportunity from Mannatech’s MLM business in other markets. Our cross-border e-commerce model in China is not an MLM or direct selling business.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170509006186/en/

CONTACT

Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report